InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Aktar Mert. Director active across 1 company, notably Kyverna Therapeutics, Inc.. Cumulatively, 1 filings have been published. Activity tracked since 27 May 2026. The latest transaction was filed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration